HM
AKRO

Harvest Management’s Akero Therapeutics AKRO Stock Holding History

Harvest Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,800
Closed -$418K – 63
2025
Q3 		$418K Buy
8,800
+1,300
+17% +$63K 0.18% 52
2025
Q2 		$400K Buy
+7,500
New +$341K 0.17% 44

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harvest Management's AKRO Position: Q4 2025 in Review

Harvest Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 8,800 shares — an estimated $418K sold.

Harvest Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $418K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Harvest Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Harvest Management sold 8,800 Akero Therapeutics shares in Q4 2025, an estimated $418K.
  • Harvest Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Harvest Management's Akero Therapeutics position peaked at $418K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Harvest Management's 13F filing for Q4 2025, filed 17 Feb 2026.